0 items USD 0.00Search
Your search for "Pharma Pipeline" gave back 41 results.
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding: ADC pipeline, ADC technologies, ADC...
Catalog:
La Merie Publishing
November 2015
Price: USD 2,500.00
T-Cell & NK-Cell Engaging Bispecific Antibo dies 2019: a business, stakeholder, technology and pipeline analysis report provides you with a...
Catalog:
La Merie Publishing
June 2019
Price: USD 2,700.00
TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals T-Cell Receptors (TCR) and Chimeric...
Catalog:
La Merie Publishing
May 2018
Price: USD 2,500.00
Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company The competitive intelligence report „ Antibody-Drug Conjugate Pipeline...
Catalog:
La Merie Publishing
December 2016
Price: USD 880.00
Report Package: Bispecific Antibodies This report package includes the full report T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a...
Catalog:
La Merie Publishing
July 2019
Price: USD 2,840.00
Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
Catalog:
IQ4I
February 2017
Price: USD 3,600.00
“ IMMUNE CHECKPOINT THERAPEUTICS – HOT TARGETS & PIPELINE ANALYSIS ” gives comprehensive insights on the various Immune Checkpoint modulators...
Catalog:
IQ4I
April 2016
Price: USD 4,500.00
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research’s latest report, "Stem Cell...
CBR Pharma Insights
July 2016
Price: USD 2,995.00
mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals For a long time, messenger RNA (mRNA)...
Catalog:
La Merie Publishing
June 2017
Price: USD 2,520.00
“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report...
Catalog:
IQ4I
December 2018
Price: USD 3,600.00
This Competitive Intelligence report about RORgamma Antagonists and Agonists evaluates the landscape of investigational small molecules targeting the...
Catalog:
La Merie Publishing
October 2019
Price: USD 280.00
“Pancreatic Beta-cell Protection Hot Targets & Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the...
Catalog:
IQ4I
August 2016
Price: USD 3,600.00
The present Competitive Intelligence report about Kallikrein Inhibitors & Bradykinin Receptor Antagonists provides a competitor evaluation in the...
Catalog:
La Merie Publishing
June 2014
Price: USD 136.00
Competitor Analysis: Inhibitors of Negative Immune Checkpoints CTLA-4, LAG-3, TIM-3 & Others This Competitive Intelligence report about...
Catalog:
La Merie Publishing
November 2016
Price: USD 550.00
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2017 Update The Competitive...
Catalog:
La Merie Publishing
November 2017
Price: USD 525.00
